Semler Scientific (SMLR) Soars 12% as Bold Bitcoin Bet Targets 105K BTC by 2027

Wall Street's latest crypto convert just doubled down—hard. Semler Scientific's stock surged 12% after announcing plans to hoard 105,000 bitcoins within three years, turning corporate treasury strategy into a high-stakes hodl.

The move makes SMLR one of the few public companies betting its balance sheet on orange coin magic. No hedging, no ETFs—just cold storage and diamond hands.

Analysts are torn between applauding the asymmetric upside and questioning if the boardroom's been mainlining hopium. 'Either they've cracked the ultimate inflation hedge,' quipped one fund manager, 'or we're witnessing the world's most expensive corporate meme.'

With Bitcoin's 2025 resurgence fueling institutional FOMO, SMLR's gamble could mint a new playbook—or become a cautionary tale for MBA case studies. Either way, shareholders just got a front-row seat to volatility theater.

TLDR

• Semler Aims for 105K BTC by 2027, Stock Jumps 12% on Strategy Update

• Joe Burnett Joins Semler to Lead Bold Bitcoin Treasury Expansion

• Semler Now Second Only to MicroStrategy in Corporate Bitcoin Holdings Plan

• Healthcare Ops Stay Active as Semler Bets Big on Bitcoin Future

• $177M BTC Gains Since 2024 Fuel Investor Optimism in Semler’s Vision

Semler Scientific(SMLR) shares jumped nearly 12% on June 18, closing at $31.94. The rally followed the company’s updated Bitcoin strategy and leadership news. In after-hours trading, the stock rose slightly to $32.00, signaling investor interest remained high.

Semler Scientific (SMLR)

The firm revealed its plan to accumulate 105,000 Bitcoins by the end of 2027. It also named bitcoin advocate Joe Burnett as its new director of Bitcoin strategy. These announcements marked a deeper shift away from traditional operations into digital asset holdings.

Investors appeared to favor the bold move, especially given recent gains in Bitcoin prices. The company saw its Bitcoin holdings appreciate significantly since adopting the strategy in May 2024. Management reaffirmed confidence in Bitcoin’s role as a long-term asset amid global economic uncertainty.

Semler Plans to Hold 105,000 Bitcoins by 2027

Semler aims to hold 10,000 Bitcoins by 2025, 42,000 by 2026, and 105,000 by 2027. The company plans to use a mix of equity financing, debt instruments and internal cash flows. Executives emphasized that the strategy will prioritize accretive value creation for shareholders.

Semler Scientific launches 3-year plan to buy 105K $BTC@SemlerSci (NASDAQ: $SMLR) has announced a 3-year plan to acquire 105,000 Bitcoin, according to @solidintel_x.

— CoinNess Global (@CoinnessGL) June 19, 2025

This initiative positions Semler as the second public U.S. firm after MicroStrategy to adopt a full-scale Bitcoin treasury model. The firm has already achieved a 287% Bitcoin yield and $177 million in gains since May 2024. With a clear roadmap, the company seeks to build one of the largest Bitcoin corporate treasuries.

Such moves come with elevated risk, as Bitcoin remains volatile and regulatory scrutiny is intensifying. Still, Semler is framing Bitcoin as a superior store of value amid fiat depreciation concerns. The company’s leadership stressed their long-term belief in Bitcoin’s monetary role.

Joe Burnett Appointed to Lead Bitcoin Strategy

Semler hired Joe Burnett to guide its Bitcoin strategy and oversee treasury operations related to digital assets. Burnett brings over seven years of experience in Bitcoin markets, financial analysis, and institutional strategy development. His recent role at Unchained focused on expanding institutional adoption of Bitcoin services.

Burnett’s appointment signals the company’s intention to professionalize and scale its treasury efforts. His background includes analytical roles at Blockware Solutions and consulting at Ernst & Young. With Burnett onboard, Semler aims to align execution with its bold accumulation targets.

His insights are expected to influence both strategic purchasing and risk management policies. Semler sees his leadership as crucial in navigating complex market and regulatory dynamics. His expertise is also expected to foster broader trust among institutional investors and partners.

Healthcare Operations Remain Active Amid Strategic Shift

Semler continues to operate its Core medical diagnostics business. Its flagship product, QuantaFlo, remains FDA-cleared and is used to assess cardiovascular conditions. The firm is also seeking expanded regulatory approval for new diagnostic indications.

Revenue from this segment supports operational cash flow, which partly funds Bitcoin acquisitions. The company maintains that healthcare and Bitcoin strategies can coexist within its broader value proposition. Ongoing innovation in health diagnostics remains on the agenda.

The dual-track approach reflects Semler’s intent to remain diversified, balancing medical product development with financial asset growth. While Bitcoin takes center stage, the firm assures stakeholders that CORE health operations will not be abandoned. The integration of both strategies has defined Semler’s current business evolution.